Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print June 6, 2002, doi: 10.1161/01.RES.0000024691.82864.F0
A more recent version of this article appeared on June 28, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/12/1333    most recent
01.RES.0000024691.82864.F0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olin-Lewis, K.
Right arrow Articles by Chait, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olin-Lewis, K.
Right arrow Articles by Chait, A.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Imaging
Right arrow Lipid and lipoprotein metabolism

Submitted on October 1, 2001
Revised on May 23, 2002
Accepted on May 23, 2002

Apolipoprotein E Mediates the Retention of High-Density Lipoproteins by Mouse Carotid Arteries and Cultured Arterial Smooth Muscle Cell Extracellular Matrices

Katherine Olin-Lewis ; Jeana L. Benton ; John C. Rutledge ; Denis G. Baskin ; Thomas N. Wight ; and Alan Chait *

From the Departments of Medicine (K.O.-L., D.G.B., A.C.) and Pathology (T.N.W.), University of Washington, Seattle, Wash; and the Department of Medicine (J.L.B., J.C.R.), University of California, Davis, Calif. Present address for T.N.W. is The Hope Heart Institute, Seattle, Wash.

* To whom correspondence should be addressed. E-mail: achait{at}u.washington.edu.

Lipoprotein retention in the vascular extracellular matrix (ECM) plays a critical role in atherogenesis. Previous studies demonstrated the presence of apo A-I and E in atherosclerotic lesions, suggesting that HDL may be trapped by the artery wall. We sought to determine mechanisms by which HDL could be bound and retained by the arterial wall, and whether apo E was a principal determinant of this binding. We evaluated in situ accumulation of fluorescently labeled DiI-human HDL±apo E in perfused carotid arteries from apo E--null mice. Apo E was important in mediating HDL binding to the vascular wall, with a 48±16% increase in accumulation of DiI-labeled apo E--containing HDL (HDL3+E) compared with DiI-apo E--free HDL (HDL3-E) (P=0.003). To investigate possible mechanisms responsible for retention, we assessed binding of unlabeled HDL3-E and HDL3+E to ECM generated by cultured arterial smooth muscle cells. Similar to the in situ carotid artery data, HDL3+E bound better to the ECM than did HDL3-E (3-fold lower Ka and 3.5-fold higher Bmax for HDL3+E versus HDL3-E). These differences were eliminated after either neutralization of arginine residues on apo E or digestion of matrix with chondroitin ABC lyase, suggesting that chondroitin and/or dermatan sulfate proteoglycans were responsible for apo E--mediated increased binding. These findings demonstrate that HDL can bind to both intact murine carotid arteries and smooth muscle cell--derived ECM, and that apo E is a principal determinant in mediating the ability of HDL to be trapped and retained via its interaction with ECM proteoglycans.


Key words: apolipoprotein E • high-density lipoproteins • extracellular matrix • artery wall • proteoglycan




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Mullick, A. F. Powers, R. S. Kota, S. D. Tetali, J. P. Eiserich, and J. C. Rutledge
Apolipoprotein E3- and Nitric Oxide-Dependent Modulation of Endothelial Cell Inflammatory Responses
Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 339 - 345.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Wyler von Ballmoos, D. Dubler, M. Mirlacher, G. Cathomas, J. Muser, and B. C. Biedermann
Increased Apolipoprotein Deposits in Early Atherosclerotic Lesions Distinguish Symptomatic From Asymptomatic Patients
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
J. Lipid Res., March 1, 2005; 46(3): 389 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. E. Thorngate, P. G. Yancey, G. Kellner-Weibel, L. L. Rudel, G. H. Rothblat, and D. L. Williams
Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
J. Lipid Res., December 1, 2003; 44(12): 2331 - 2338.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Mullick, R. J. Deckelbaum, I. J. Goldberg, M. Al-Haideri, and J. C. Rutledge
Apolipoprotein E and Lipoprotein Lipase Increase Triglyceride-Rich Particle Binding but Decrease Particle Penetration in Arterial Wall
Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2080 - 2085.
[Abstract] [Full Text] [PDF]